BerGenBio ASA (OSL: BGBIO)
Norway
· Delayed Price · Currency is NOK
10.37
+2.35 (29.37%)
Nov 21, 2024, 4:25 PM CET
BerGenBio ASA Market Cap
BerGenBio ASA has a market cap or net worth of 405.26 million as of November 21, 2024. Its market cap has decreased by -14.84% in one year.
Market Cap
405.26M
Enterprise Value
230.41M
Revenue
521.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
10.37
Market Cap Chart
Since April 7, 2017, BerGenBio ASA's market cap has decreased from 1.24B to 405.26M, a decrease of -67.41%. That is a compound annual growth rate of -13.67%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nordhealth AS | 2.96B |
Medistim ASA | 2.42B |
Carasent ASA | 1.45B |
Photocure ASA | 1.37B |
Nykode Therapeutics AS | 819.63M |
ArcticZymes Technologies ASA | 676.19M |
Gentian Diagnostics ASA | 616.89M |
Hofseth BioCare ASA | 554.96M |